Hier werden die Unterschiede zwischen zwei Versionen angezeigt.
Beide Seiten der vorigen Revision Vorhergehende Überarbeitung Nächste Überarbeitung | Vorhergehende Überarbeitung Nächste Überarbeitung Beide Seiten der Revision | ||
pelargonium_sidoides_dc [2015/12/17 12:33] andreas |
pelargonium_sidoides_dc [2017/07/01 11:41] andreas |
||
---|---|---|---|
Zeile 17: | Zeile 17: | ||
The root extract (EPs® 7630) contained coumarins like [[https:// | The root extract (EPs® 7630) contained coumarins like [[https:// | ||
"EPs® 7630 respectively the contained proanthocyanidins reduce the adhesiveness of group A streptococci by up to 47% (at an incubation concentration of 30 µg/ml). Here, the trihydroxylation of the B ring of the flavan-3-ol-subunits is of crucial importance for the activity, while the degree of polymerization plays a subordinate role. \\ | "EPs® 7630 respectively the contained proanthocyanidins reduce the adhesiveness of group A streptococci by up to 47% (at an incubation concentration of 30 µg/ml). Here, the trihydroxylation of the B ring of the flavan-3-ol-subunits is of crucial importance for the activity, while the degree of polymerization plays a subordinate role. \\ | ||
- | EPs® 7630 has a remarkably high inhibitory activity against neuraminidase (IC50 ca. 1 uGu/ml). The commercially available drugs zanamivir (IC50 ca. 18 µg/ml) and oseltamivir carboxylate (IC50 ca. 54 µg/ml) are considerably less active in the used in vitro model. The enzyme is significantly inhibited by proanthocyanidins, | + | EPs® 7630 has a remarkably high inhibitory activity against neuraminidase (IC50 ca. 1 µ/ml). The commercially available drugs zanamivir (IC50 ca. 18 µg/ml) and oseltamivir carboxylate (IC50 ca. 54 µg/ml) are considerably less active in the used in vitro model. The enzyme is significantly inhibited by proanthocyanidins, |
[Beitrag zur Kenntnis der Inhaltsstoffe und der Wirkung des Pelargonium sidoides Spezialextraktes EPs® 7630., Janecki, A., (Doctoral dissertation, | [Beitrag zur Kenntnis der Inhaltsstoffe und der Wirkung des Pelargonium sidoides Spezialextraktes EPs® 7630., Janecki, A., (Doctoral dissertation, | ||
Zeile 26: | Zeile 26: | ||
"After having conducted a hearing within a graduated plan (" | "After having conducted a hearing within a graduated plan (" | ||
[Medicinal products containing pelargonium: | [Medicinal products containing pelargonium: | ||
+ | |||
+ | |||
+ | {{http:// | ||
+ | Pelargonium sidoides, 3. Botanischer Garten der Universität Wien (HBV) 2017; author: Rolf Marschner, | ||
+ | [[http:// | ||
+ |